Titlebook: Coronary Microvascular Dysfunction; Filippo Crea,Gaetano A. Lanza,Paolo G. Camici Book 2014 The Editor(s) (if applicable) and The Author(s

ENNUI

Health promotion in the workplace,d myocardial damage in patients undergoing CABG surgery have included ischemic conditioning and drugs, as adenosine and acadesine, diazoxide, volatile anesthetic agents, anti-inflammatory agents, statins and sodium–hydrogen exchange inhibitors. The results achieved with these forms of treatment are discussed in this chapter.

Serenity

ormation on the prevention and treatment of coronary microva.In the past two decades a number of studies have shown that abnormalities in the function and structure of coronary microcirculation can be detected in several cardiovascular diseases. On the basis of the clinical setting in which it occur

背书

追踪

OCTO

吊胃口

Fulminate

Treatment of Primary CMDthis chapter. While the pharmacological approach to acute MVA still waits to be defined, treatment of takotsubo disease is mainly based on the control of hemodynamic state, due to the usual spontaneous improvement of the disease.

吗啡

Treatment of CMD in Obstructive CADcluding pharmacological (e.g., adenosine, nitroprusside) and nonpharmacological (e.g., antiembolic devices, ischemic conditioning) tools. This chapter discusses the main results observed with these interventions in these clinical settings.

maroon

Accomplish

Book 2014to the pathogenesis of myocardial ischemia, thus becoming a possible therapeutic target. This book provides an update on coronary physiology and a systematic assessment of microvascular abnormalities in cardiovascular diseases, in the hope that it will assist clinicians in prevention, detection and management of CMD in their everyday activity..